Pages that link to "Q45933644"
Jump to navigation
Jump to search
The following pages link to Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine. (Q45933644):
Displaying 35 items.
- Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations (Q28534686) (← links)
- Clinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions. (Q30234940) (← links)
- Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma (Q30940472) (← links)
- Xenobiotic, bile acid, and cholesterol transporters: function and regulation. (Q33714593) (← links)
- Colchicine for the treatment of gout (Q33738046) (← links)
- Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance (Q34065294) (← links)
- Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development (Q34273688) (← links)
- Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer (Q35090489) (← links)
- Preparation and in vitro evaluation of hydrophilic fenretinide nanoparticles (Q35137881) (← links)
- Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide (Q35706314) (← links)
- Improved Bioavailability and Antitumor Effect of Docetaxel by TPGS Modified Proniosomes: In Vitro and In Vivo Evaluations (Q37684088) (← links)
- Multidrug resistance in the chronic lymphoproliferative disorders (Q37771031) (← links)
- Mechanistic enhancement of the intestinal absorption of drugs containing the polar guanidino functionality (Q37828505) (← links)
- Efflux pump-mediated resistance in chemotherapy (Q38084554) (← links)
- Pharmacokinetics considerations for gout treatments (Q38210284) (← links)
- Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations (Q38874008) (← links)
- Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification (Q39205354) (← links)
- Phyllanthin and hypophyllanthin inhibit function of P-gp but not MRP2 in Caco-2 cells (Q39218330) (← links)
- Colchicine toxicity precipitated by interaction with sunitinib (Q40255948) (← links)
- Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir (Q41203734) (← links)
- Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine (Q41986927) (← links)
- The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane (Q41986961) (← links)
- The fraction dose absorbed, in humans, and high jejunal human permeability relationship (Q42131253) (← links)
- Determination of intestinal permeability of rigosertib (ON 01910.Na, Estybon): correlation with systemic exposure (Q46329890) (← links)
- Absorption sites of orally administered drugs in the small intestine (Q50049609) (← links)
- Modern prodrug design for targeted oral drug delivery. (Q51042522) (← links)
- The Solubility–Permeability Interplay: Mechanistic Modeling and Predictive Application of the Impact of Micellar Solubilization on Intestinal Permeation (Q53413055) (← links)
- Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the Permeability. (Q53502218) (← links)
- Ezrin regulates the expression of Mrp2/Abcc2 and Mdr1/Abcb1 along the rat small intestinal tract. (Q54405469) (← links)
- Segmental-dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In Vivo Permeability Values (Q57099840) (← links)
- In Vitro and In Situ evaluation of pH-dependence of atazanavir intestinal permeability and interactions with acid-reducing agents (Q57109564) (← links)
- A Comprehensive Study Demonstrating that P-glycoprotein Function is Directly Affected by Changes in pH: Implications for Intestinal pH and Effects on Drug Absorption (Q57343266) (← links)
- Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report (Q58703969) (← links)
- Study on the mechanism of intestinal absorption of epimedins a, B and C in the Caco-2 cell model (Q87055501) (← links)
- Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development (Q90663665) (← links)